Arcascope

Executive Summary

Arcascope is a digital health company specializing in circadian rhythm science and personalized sleep/wake scheduling. Founded in 2014 and based in Ann Arbor, Michigan, the company develops computational models that analyze individual circadian biology to optimize sleep, alertness, and overall health. Its technology serves both research institutions—aiding in studies on circadian rhythms—and individual consumers seeking data-driven sleep improvement. By leveraging mathematical modeling, Arcascope provides insights that can help mitigate the health impacts of shift work, jet lag, and irregular sleep patterns. The company operates in the growing digital health and sleep tech market, which is expanding due to increased awareness of sleep’s role in wellness and productivity. Despite a strong scientific foundation, Arcascope faces challenges common to early-stage digital health firms: securing clinical validation, navigating regulatory pathways, and scaling commercial adoption. The company has not disclosed funding rounds or valuation, suggesting it may be operating with limited resources. However, its focus on circadian biology—an area with rising interest from employers, healthcare providers, and pharmaceutical companies—positions it for potential growth. Key opportunities include partnerships with wearable device manufacturers or integration into employee wellness programs. To succeed, Arcascope must demonstrate measurable outcomes in clinical settings and differentiate its offering in a competitive landscape.

Upcoming Catalysts (preview)

• Q4 2026Launch of a direct-to-consumer circadian optimization app40% success
• Q2 2027Strategic partnership with a major sleep research institution or wearable maker30% success
• Q1 2027Publication of peer-reviewed clinical study validating circadian model accuracy50% success